However, specific gene mutations have not been defined, although we did identify RASSF1A methylation in 55% of NBs and that CASP8 methylation occurs in ∼50% of tumours (Teitz et al, 2000; Astuti et al, 2001). Here, CASP8 is linked to neoplasm.